Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 21 Απρ 2023 · The epidemiology, clinical features, diagnosis, and treatment of infections due to K. pneumoniae will be reviewed here. The microbiology and pathogenesis of K. pneumoniae infection are discussed separately.

  2. 13 Ιουν 2020 · Treatment for pneumonia involves curing the infection and preventing complications. People who have community-acquired pneumonia usually can be treated at home with medication. Although most symptoms ease in a few days or weeks, the feeling of tiredness can persist for a month or more.

  3. 18 Αυγ 2022 · Summary. We retrospectively analyzed published data on the use and outcomes of antimicrobial therapy for K. pneumoniae infections. We discussed plazomicin, eravacycline, fosfomycin, tigecycline, and polymyxin as prevalent therapeutic options.

  4. Until very recently, the pipeline of new drugs for the treatment of multidrug-resistant gram-negative pathogens had been described as “dry”. However, a number of new drugs with in vitro activity against multidrug-resistant strains of K. pneumoniae are now in development.

  5. 20 Ιουλ 2023 · Objectives: Describe the pathophysiology of Klebsiella. Identify the most common cause of hospital-acquired pneumonia in the United States. Recall patients most likely to get Klebsiella pneumonia. Review the evaluation and treatment of patients with Klebsiella pneumonia and the interprofessional team's role in managing patients with this condition.

  6. 14 Μαΐ 2020 · The aim of this review is to discuss the challenges in the management and treatment of patients with infections because of K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) and provide an expert opinion.

  7. 28 Μαρ 2023 · Purpose. The clinical characteristics of Klebsiella pneumoniae (KP) pneumonia and KP bloodstream infection (KP-BSI) are often reported, while the risk factors for KP pneumonia developing into secondary KP-BSI (KP-pneumonia/KP-BSI) are largely unknown.

  1. Γίνεται επίσης αναζήτηση για